Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |